Skip to main content
logo
Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0310
+0.0080 (34.78%)
At close: Jul 21, 2026

Iterum Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.39-----
Revenue Growth
------
Gross Profit
0.12-0.25----
Operating Income
-20.64-18.7-47.47-30.38-24.54-32.13
Net Income
-26.96-24.77-38.37-44.43-91.56-52.01
Earnings Per Share
-0.74-1.26-2.96-3.63-8.41-32.49
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
1124.1323.9360.881.3816.87
Total Debt
33.7445.619.5130.130.4348.08
Net Cash (Debt)
-22.73-21.484.4230.750.96-31.22
Net Cash Growth
---85.60%-39.75%--
Net Cash Per Share
-0.62-1.090.342.514.68-19.50

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-19.51-26.77-39.33-18.47-15.84-54.53
Capital Expenditures
-0.01-0-0.01-0.06-0.06-0.01
Free Cash Flow
-19.53-26.77-39.34-18.54-15.9-54.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
29.74%-----
Operating Margin
-5292.31%-----
Profit Margin
-6913.08%-----
FCF Margin
-5007.18%-----

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
4.20-----